Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Optimal prevention of CVD in patients with HIV includes attention to risk factors such as tobacco use, hyperlipidemia, hypertension, glucose abnormalities, obesity, family history of CVD, and metabolic syndrome
  • Patients should be educated about CVD risks using interventions directed at those factors that are modifiable and with referral to dietary support and exercise programs as needed
  • Smoking is a critical modifiable risk factor that should be addressed in patients with HIV[Petoumenos 2011]

Action required